442
Participants
Start Date
December 31, 2004
Primary Completion Date
March 31, 2007
Study Completion Date
January 31, 2011
Cetuximab + Platinum (Cisplatin or Carboplatin) + 5Fluorouracil (5-FU)
Subjects in will receive initial dose of 400 mg/m\^2 cetuximab (over 2 hours) followed by weekly doses of 250 mg/m\^2 (over 1 hour). All doses will be given by intravenous (IV) infusion. Subjects will receive either Cisplatin (100 mg/m\^2 on day 1) + 5-FU (1000 mg/m\^2 continuous IV from day 1 to day 4) every 3 weeks or Carboplatin (Area under the curve (AUC) 5 IV on day 1) + 5-FU (1000 mg/m\^2 continuous IV from day 1 to day 4) every 3 weeks
Platinum (Cisplatin or Carboplatin) + 5-FU
All doses will be given by IV infusion. Subjects will receive either Cisplatin (100 mg/m\^2 on day 1) + 5-FU (1000 mg/m\^2 continuous IV from day 1 to day 4) every 3 weeks or Carboplatin (AUC 5 IV on day 1) + 5-FU (1000 mg/m\^2 continuous IV from day 1 to day 4) every 3 weeks
Research Site, Innsbruck
Research Site, Vienna
Research Site, Brussels
Research Site, Edegem
Research Site, Ghent
Research Site, České Budějovice
Research Site, Prague
Research Site, Caen
Research Site, Dijon
Research Site, Lille
Research Site, Limoges
Research Site, Marseille
Research Site, Montpellier
Research Site, Nantes-Saint Herblain
Research Site, Nice
Research Site, Strasbourg
Research Site, Toulouse
Research Site, Tours
Research Site, Vandœuvre-lès-Nancy
Research Site, Berlin
Research Site, Essen
Research Site, Frankfurt on the Main
Research Site, Hamburg
Research Site, Munich
Research Site, Oldenburg
Research Site, Stuttgart
Research Site, Budapest
Research Site, Győr
Research Site, Kecskemét
Research Site, Nyíregyháza
Research Site, Cuneo
Research Site, Genoa
Research Site, Milan
Research Site, Monserrato
Research Site, Naples
Research Site, Rome
Research Site, Amsterdam
Research Site, Nijmegen
Research Site, Gdansk
Research Site, Krakow
Research Site, Warsaw
Research Site, Lisbon
Research Site, Porto
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Bratislava
Research Site, Košice
Research Site, Barcelona
Research Site, Donostia / San Sebastian
Research Site, L'Hospitalet de Llobregat
Research Site, Madrid
Research Site, Málaga
Research Site, Santander
Research Site, Seville
Research Site, Valencia
Research Site, Lind
Research Site, Örebo
Research Site, Umeå
Research Site, Geneva
Research Site, Thun
Research Site, Zurich
Research Site, Donetsk
Research Site, Kharkiv
Research Site, Kiev
Research Site, Sumy
Research Site, Chelmsford
Research Site, Edinburgh
Research Site, London
Research Site, Manchester
Research Site, Nottingham
Merck KGaA, Darmstadt, Germany
INDUSTRY